According to Research by SNS Insider, U.S. Bone Growth Stimulator Market is projected to hit USD 990 Million by 2032 as aging populations, chronic bone disorders, and demand for post-operative ...

Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth stimulator system that reportedly promotes healing and encourages patient compliance during ...

These 10 stocks could mint the next wave of millionaires › Orthofix Medical (NASDAQ:OFIX), a medical device and biologics company specializing in spinal, orthopedic, and bone growth products, reported ...

A bone stimulator is a tiny device that sends low-voltage electrical impulses straight to the spine region where bone formation (spine fusion) is about to begin.New York, June 28, 2022 (GLOBE ...

The Xstim device is a non-invasive bone growth stimulator for patients to use during therapy after spinal fusion surgery, according to the release. Xstim Inc. received FDA premarket application ...

Global Bone Growth Stimulators Market to Reach $1.5 Billion by 2030 The global market for Bone Growth Stimulators estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of ...

This latest patent acknowledges ActaStim-S' contemporary design, the first new post-op, spine fusion, bone growth stimulator in decades.

The first new Spine Fusion Stimulator on the market in decades, ActaStim-S blends clinically proven therapeutic stimulation with modern design and a data-rich digital health platform. The system ...